Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis

Based on a large cohort of clinical studies involving a total of 8024 patients and reporting the effects of HER4 on breast cancer prognosis, we conducted the first meta-analysis and review of this type. We identified 26 studies published between 1985 and 2016 and assessed the prognostic value of HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jue, Yin, Jun, Yang, Qing, Ding, Feng, Chen, Xiao, Li, Bingjie, Tian, Xingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363541/
https://www.ncbi.nlm.nih.gov/pubmed/27736797
http://dx.doi.org/10.18632/oncotarget.12485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363541/
https://www.ncbi.nlm.nih.gov/pubmed/27736797
http://dx.doi.org/10.18632/oncotarget.12485

Ejemplares similares